Clinical Trials Logo

Detrusor Hyperreflexia clinical trials

View clinical trials related to Detrusor Hyperreflexia.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00583219 Completed - Overactive Bladder Clinical Trials

Botulin-A Toxin Instillations and Overactive Bladder

Start date: March 2006
Phase: Phase 1/Phase 2
Study type: Interventional

The primary objective of this pilot study is to evaluate the safety and efficacy of direct instillations of Botulinum-A toxin/DMSO into the bladder via a catheter system as a means of treating women with symptoms of overactive bladder and secondary urinary incontinence. In doing so, we will focus on estimating the percentage of women who experience an improvement in their urinary incontinence symptoms at one month and three months following this novel instillation technique.

NCT ID: NCT00224029 Completed - Clinical trials for Detrusor Hyperreflexia

A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition

Start date: December 2004
Phase: Phase 4
Study type: Interventional

This study will evaluate the efficacy and safety of an anticholinergic drug treatment administered by transdermal patch to treat overactive bladder in adults who have spinal cord injury.

NCT ID: NCT00224016 Completed - Clinical trials for Detrusor Hyperreflexia

Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition

Start date: December 2004
Phase: Phase 4
Study type: Interventional

This study will evaluate the safety and effectiveness of an anticholinergic drug treatment administered by transdermal patch to treat overactive bladder in children who have a neurological condition (e.g. spina bifida) that contributes to their overactive bladder.